Beijing haidian hospital
🇨🇳China
Clinical Trials
6
Active:0
Completed:1
Trial Phases
3 Phases
Phase 2:2
Phase 4:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (50.0%)Not Applicable
1 (25.0%)Phase 4
1 (25.0%)Exploratory Study of the Microbiome of Upper Gastrointestinal in the Pathogenesis of Multiple Primary Lung Cancer
Completed
- Conditions
- Multiple Primary Lung CancerMicrobial Colonization
- First Posted Date
- 2025-05-15
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Beijing Haidian Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06973499
- Locations
- 🇨🇳
Beijing Haidian Hospital, Beijing, China
Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2021-09-05
- Lead Sponsor
- Beijing Haidian Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT05034133
- Locations
- 🇨🇳
Beijing Haidian Hospital, Beijing, China
Diagnostic Value of CircRNA-Uck2 for Acute Myocardial Infarction
Not Applicable
- Conditions
- Cardiac DiseaseAcute Myocardial InfarctionDiagnoses Disease
- First Posted Date
- 2017-05-31
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Beijing Haidian Hospital
- Target Recruit Count
- 178
- Registration Number
- NCT03170830
- Locations
- 🇨🇳
Beijing Haidian Hospital, Haidian Section of Peking University Third Hospital, Beijing, China/Beijing, China
Clinical Characteristics and Microbiology of Community-Acquired Pneumonia
- Conditions
- Community-acquired Pneumonia
- First Posted Date
- 2017-04-04
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- Beijing Haidian Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT03098914
- Locations
- 🇨🇳
Beijing Haidian Hospital, Beijing, Beijing, China
The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR Mutation
- First Posted Date
- 2016-06-30
- Last Posted Date
- 2016-06-30
- Lead Sponsor
- Beijing Haidian Hospital
- Target Recruit Count
- 67
- Registration Number
- NCT02820116
- Locations
- 🇨🇳
Beijing Haidian Hospital, Beijing, Beijing, China
- Prev
- 1
- 2
- Next
News
No news found